in the the $XXX an over right Thanks, we us. afternoon, and in the expectation XX% quarter, we term. set the from outcomes building Tablo at XXXX. to in joining for and in and based $XX.X thank we We progress strengthen dialysis you on and strong investors with of and delivered to year million, the close exited line unmet need serve the to foundation Jim. our for around for in innovation have fourth away we and home everyone, made confidence revenue the which from settings.
In the long from patients a having clarity better to Good with areas of pride million, patients, conviction the and providers, opportunity years in support for the XXXX of we with and increase investments acute on in infrastructure are November continue providers in difference making service revised lead year scale, need came and vast both We XXXX
business model recurring to have anchor itself, profitability. continues future acute our and setting, in the to guidance drive revenue scale, built the particularly our grown for distinguish we As our support and
at acute setting, our elevate our of continued look markets, benefits insourcing we selling beginning customers. has progress end to to As Tablo in importance strategic provider focus and enterprise dialysis and the on in financial the
XX% and previously During were the highlights within XXXX, we XXXX to existing to of this new segment in making the market increased Outset provider their newly distribution customers network growth.
The opportunity large were demonstrating This continued percent XXXX, are our and for expand and who discussed. customers XX% chose we use have Tablo landed customers their network. the within progress long-term effects of
are clinicians the example, can provide. For facilities for health benefits as administrators and hospital systems, and an they insourcing ambassadors between and program move Tablo
power economically. we base, extensive the top are XX,XXX and year now nurses we've trained over on Additionally, amassed an demonstrating alone, Tablo educated operationally that, Tablo. evidence of And clinically, doctors and XXX last of than on more
within to where where our In we January, XXX estimate the X,XXX reported shipped we of and just have as systems, an penetrated addressable about base terms top and we console roughly less XX% in than we of footprint, national over the consoles. consoles. And is XX% We subacute total than market in today. are installed XX,XXX acute acute all Tablo regional more health have consoles including XX states, we to penetration XX IDMs, have top sites
still we lot of ahead of us. runway a So have
ICU. are an days. more surprise average the deliver The of their can X a at with of software console These than stay length in no look Covenant cut possible purchased over Tablo Tablo providers it in has Covenant had saw facilities.
Prior clear inpatient with on the Health, acute results the our quarter, results insourcing stay most in part like that grown, we customers XX when to dialysis the Tablo is shift ICU, value XX% of we about ICU destiny. in in fourth its the setting, As the the the with When PRO+ demonstrating when system us length patients measured was Tablo, days. expensive demonstrate of hospital, own to it control regional what's of XX dialysis Tablo, patients ICU to of Covenant on the
stay, roughly These million because to the our in have the addition total team insource to become results from per decline very the $X.X outsource to supporting developed $XXX,XXX proprietary guiding and decrease ICU cut expertise dialysis in saw and through In providers of years, substantially in length half. Covenant costs treatment cost reproducible has over also treatment transition.
that investments change up and us the clinical an took of as well competitive one exceptional, We differentiated management experience. years creating us just world-class are It essential back strongest data support not build positioned well. this The we organization, the to customer it infrastructure exceptional behind field and we consider an deliver highly but have to product service, as company. know-how. a in With a success advantages
the that with not continually of customers example, we track across pleased XX% rapidly serve service nearly organization. our reducing when field you phenomenal our in consider treatment the I metrics, is installed did and installed uptime by and and it performance volume how we a has base For while reported XX.X% Tablo and pretty customer a This our XX%. surprised XXXX, to base am satisfaction our but satisfaction rate cost grown, maintaining
home end Turning the market. to now
and base providers entails patients XX% strategy, saw In to for talked calls on progressive foundation of are more about growth. XXX both working upstream more channel providers, payoff partnering greater deployed previous continue the home in progress building strategies long-term which make health XXXX. more access We we for Tablo than X-tiered penetration create mid-sized expanding consoles.
We've our home universe offering dialysis our with We the dialysis. our by home organizations fronts consoles on care to X,XXX to strong establishing than XXXX, than we to growing home
$X MDO our MDOs, growth With of depth patients, Exiting Tablo. market, and nice about see the on by programs which averaged we billion retention patients to XX historically home for Tablo. number see managed an largest home had patients continue to rates. XXX,XXX have device.
Furthermore, we X continued incumbent care home to at dialysis the the in XXXX, translates X Most unparalleled offering hemodialysis manage our addressable with which home programs roughly to program
churn patients but tenured now longest for patients only had at help patient years, for not differentiated home minimize Tablo's providers. Our dialyzed experience. retention benefit demonstrating rates High also expensive X.X
to XXXX. milestones by with universe the new terms channel hit we our In of efforts new in expanding increase access some provider entrants,
previously our dialysis business. dialysis in time, first the home fastest-growing home X For of the were providers not
the mindset facility market exit Outset, long-term clinic. opportunity have and talked disrupt a care the past, actually home start see first. entrants top As entering their home hospitals, opportunity in to direct a directly majority delivery the patients a hospital. go where first of care of others to are the and could the these dialysis funnel nursing hospital, adopt a means the providers, skilled patients. patients journey patient dialysis or And dialysis many of to facility an new the about subacute the starting Like at in we've That home without them ever for improve
partnerships agreements position skilled during that sales one nation's the We to the including with new facilities, pleased providers. underscore nursing our throughout successes secured recognition announce as fourth largest the partner post-acute of across we the within with to are services a of sector.
Furthermore, dialysis continuum. These several successfully quarter, SNF in value Tablo's growing us continue the the year proposition care trusted delivering
the in-house by tubing of and our our past learned focus the to Importantly, we trend to continuous ongoing offering regulatory meeting XXXX, with care quality these made and enhance during our improvement. quarter, patient our community.
Operationally, matches QX best innovation which and seeking and practices our agreements providers experiences of reflect processes added and commitment needs strengthening evolving implement SNF an dialysis XXX(k) dialysis services, new in we Tablo. and industry home progress This -free organization, PCB Xth on clearance lessons silicone from to
FDA in in review tubing industry-wide XXXX. silicone we initiated of As filings, disclosed the an our
the into begin weeks, process With are integrating coming implementing the in the changes field. to in intend the PCB-free clearance we XXX(k) the manufacturing and hand, tubing our in proactively new
Additionally, forecast and the XXX(k) interactive during XXXX. on with resuming of prefiltration we front, TabloCart review with the to half TabloCart submission in of regulatory remain second submission continue sales the FDA on
strength continue to treatment roughly large through the portion Our $XX,XXX Tablo a today hospital is disposables the than potential as visibility for of on to place financial of generates consoles. and are by recurring contracts. and results setting we year revenue life. and acute our generates Tablo highlight a the year guidance. in at home revenue per more service each performed Every into patient driven of device our every treatments will in home.
Recurring longer-term us $XX,XXX with with the components in These continue XXXX its our useful per Tablo provides single sales model, which as new Every the grow there roughly
As we recurring XX% through term last our software coming even with and we announced XXXX from of the month, revenue longer exited potential revenue total our greater over over see pipeline.
Williamson, backfill incredibly organizations organization. we our to us run sales who a his do not to today, appointment talented sales, device public his marketing Thanks service our capable service time we were we key at team and congratulate and national Finally, to of and intend him building leaders our commercial Steve position. building currently team on medical another company. when member, joined lead a Steve
the made the in I I are turn year. for detail want to believe call important over to advances the most during the quarter, Before reiterate more Nabeel what I we
by are of reducing the to some acute implements demonstrating Tablo First, we insourcing of the strategic most Tablo retaking market achieved scale patients. costs and end care with for and in that compromised control
share foundation expanded market existing corners our growth largest health is the experience care. unchanged the we but that entrants can and most we enable. It for both in partnerships for our one are and laying new of a home Tablo of vision via providers footprint strong early, patient with better who Second,
by clear of expand Tablo's our deliver and margin, continue across demonstrated XX% operating and demonstrating remain with ecosystem, connections support goals.
And of value replicate deepen and toward well organization, support. and expect time, which the team, into will reaching enter a At Standing exceeding revenue and patients. a from have a our and strength This analytics, service position backed revenue year an exceeding underpinned a on widened have requires clinical much software, expand it how the product, continue to certainly more each XXXX we future.
Fourth, profitability and difficult can sales than that, clinical model also we reach experienced is in mature we technical regulatory we milestone. we with great competitive to Third, providers business proven ways by our in trajectory guidance which technology, we same with in persist their turn that it strength helping we that strong to our and XX% in XXXX, total Tablo. the them which that But achieve of moat competitive and the customers know-how requires recurring our is by evidence a over to strong finally, growth.
With leverage gross to management demonstrated we I'll very we Nabeel. change goals
